SoftBank Vision Fund 2, PICC Capital and Morningside co-led a $318 million financing of XtalPi, an artificial intelligence-based drug discovery and development company based in Massachusetts and China.
Founded in 2014 by a group of quantum physicists at MIT, XtalPi has since built a team with multi-disciplinary expertise in physics, chemistry, pharmaceutical R&D and algorithm design. XtalPi's cutting-edge technologies have led to the establishment of strategic partnerships with top international pharmaceutical companies.
The SoftBank Vision Fund was formed to accelerate the AI revolution through investments in market . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.
